Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease
Open Access
- 7 September 2017
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 39 (26) , 2497-2505
Abstract
Despite strong indications that increased consumption of added sugars correlates with greater risks of developing cardiometabolic syndrome (CMS) and cardiovascular disease (CVD), independent of the caloric intake, the worldwide sugar consumption remains high. In considering the negative health impact of overconsumption of dietary sugars, increased attention is recently being given to the role of the fructose component of high-sugar foods in driving CMS. The primary organs capable of metabolizing fructose include liver, small intestine, and kidneys. In these organs, fructose metabolism is initiated by ketohexokinase (KHK) isoform C of the central fructose-metabolizing enzyme KHK. Emerging data suggest that this tissue restriction of fructose metabolism can be rescinded in oxygen-deprived environments. In this review, we highlight recent progress in understanding how fructose metabolism contributes to the development of major systemic pathologies that cooperatively promote CMS and CVD, reference recent insights into microenvironmental control of fructose metabolism under stress conditions and discuss how this understanding is shaping preventive actions and therapeutic approaches.Keywords
Funding Information
- Swiss Heart Foundation
- SNF
- NIH (NIDDK DK107667)
This publication has 135 references indexed in Scilit:
- RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean DietNew England Journal of Medicine, 2013
- A Randomized Trial of Sugar-Sweetened Beverages and Adolescent Body WeightNew England Journal of Medicine, 2012
- Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin ResistanceCell Metabolism, 2012
- The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trialMetabolism, 2011
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2010
- Increased Fructose Consumption Is Associated With Fibrosis Severity in Patients With Nonalcoholic Fatty Liver DiseaseHepatology, 2010
- Caloric Sweetener Consumption and Dyslipidemia Among US AdultsJAMA, 2010
- Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular DiseaseGastroenterology, 2008
- Fructose consumption as a risk factor for non-alcoholic fatty liver diseaseJournal of Hepatology, 2008
- Hypoxia increases expression of selective facilitative glucose transporters (GLUT) and 2-deoxy-d-glucose uptake in human adipocytesBiochemical and Biophysical Research Communications, 2007